公司概覽
業務類別 Biotechnology
業務概覽 Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
公司地址 1800 Owens Street, Suite 900, San Francisco, CA, USA, 94158
電話號碼 +1 415 906-4324
傳真號碼 --
公司網頁 https://www.vir.bio
員工數量 367
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Marianne De Backer, M.B.A.,M.Sc.,PhD Director, President and Chief Executive Officer 美元 950.00K 04/03/2026
Mr. Aziz Sawaf, C.F.A. Executive Vice President and Chief Financial Officer -- 01/10/2026
Mr. Brent Sabatini Senior Vice President and Chief Accounting Officer -- 01/10/2026
Ms. Vanina de Verneuil Executive Vice President, General Counsel and Corporate Secretary 美元 506.33K 16/04/2026
 
董事會成員
董事會 職務 更新日期
Dr. Elliott Sigal, M.D.,PhD Independent Director 16/04/2026
Professor Dr. Norbert W. Bischofberger, PhD Independent Director 16/04/2026
Mr. Robert J. More Independent Director 16/04/2026
Mr. Timothy P. Coughlin Director 10/06/2026
Ms. Sona Saira Ramasastry, M.Phil,M.S. Independent Director 16/04/2026
Mr. Jeffrey S. Hatfield Independent Director 16/04/2026
Dr. Marianne De Backer, M.B.A.,M.Sc.,PhD Director, President and Chief Executive Officer 04/03/2026
Dr. Ramy Farid, PhD Independent Director 16/04/2026
Ms. Janet Napolitano, J.D. Independent Director 16/04/2026
Ms. Suzanne Topalian, M.D. Independent Director 28/10/2026
 
所屬ETF (更新日期: 14/11/2026 03:51)
代號 名稱 佔比% ▼ 持有日期
DFUSDimensional US Equity Market ETF0.03%30/10/2026
IWViShares Russell 3000 ETF0.02%30/10/2026
RWJInvesco S&P SmallCap 600 Revenue ETF0.02%30/10/2026
AVUSAvantis US Equity ETF0.02%30/10/2026
BBCVirtus Biotech Clinical Trials ETF0.02%30/10/2026
DCORDimensional US Core Equity 1 ETF0.01%24/09/2026
NIXTResearch Affiliates Deletions ETF0.01%30/10/2026
QVMSInvesco S&P SmallCp 600 QVM Mlt-fctr ETF0.01%30/10/2026
XJRiShares ESG Select Scrn S&P Small-CapETF0.01%30/10/2026
SPTMState StreetSPDRPortS&P1500CompStkMktETF0.01%30/10/2026
ISCGiShares Morningstar Small-Cap Growth ETF0.01%30/10/2026
ISCViShares Morningstar Small-Cap Value ETF0.01%30/10/2026
IBBQInvesco Nasdaq Biotechnology ETF0.01%30/10/2026
TECBiShares US Tech Breakthrough Mltsctr ETF0.01%30/10/2026
VTHRVanguard Russell 3000 ETF0.01%30/09/2026
TILTNorthern Trust Mstar US Mkt Fac Tlt ETF0.01%30/10/2026
DFSUDimensional US Sustainability Core 1 ETF0.01%30/10/2026
WSMLiShares MSCI World Small-Cap ETF0.01%30/10/2026
ITWOProShares Russell 2000 High Income ETF0.005%30/10/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.004%30/10/2026
  1    2   3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.